Prof. Dr. Özlem Er
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Breast Neoplasms 8 publicationsSource: OpenAlex / PubMed MeSHView publications
- Lung Neoplasms 7 publications
- Colorectal Neoplasms 6 publications
- Neoplasms 4 publications
- Stomach Neoplasms 4 publications
- Rectal Neoplasms 3 publications
- Carcinoma, Squamous Cell 3 publications
- Mesothelioma 3 publications
- Paraneoplastic Syndromes 2 publications
- Carcinoma, Non-Small-Cell Lung 2 publications
- Adenocarcinoma 2 publications
- Brain Neoplasms 2 publications
- Uterine Neoplasms 2 publications
- Bone Neoplasms 2 publications
- Carcinoma 2 publications
- Hypercalcemia 2 publications
- Kidney Neoplasms 2 publications
- Carcinoma, Small Cell 2 publications
- Superior Vena Cava Syndrome 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: acibadem.com.tr.
- Gastrointestinal Onkoloji
- Jinekolojik Tümörler ve Kanserler (Rahim, Serviks, Yumurtalık/Over Kanseri vb.)
- İmmunoterapi ve Hedefe Yönelik Tedaviler
- Pankreas Kanseri
- Nazofarenks Kanseri
- Mesane Kanseri
- Meme Kanseri
- Kolorektal Kanserler (Kolon ve Rektum Kanseri)
- Ağız Kanseri
- Baş Boyun Kanserleri
- Beyin Tümörleri
- Böbrek Kanseri
- Böbrek Üstü Bezi Kanseri
- Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
- Malign Melanom ve Diğer Deri Tümörleri
- Kolon (Kalın Bağırsak) Kanseri
- Akciğer Kanseri
CV
Education and experience
Experience
- 2018Acıbadem Sağlık Grubuacibadem.com.tr
- 2006 - 2008Thomas Jefferson Üniversitesi Meme Kanseri Araştırma (Research Fellow)acibadem.com.tr
- 2005 - 2007Erciyes Üniversitesi Tıp Fakültesi Medikal Onkoloji Anabilim Dalı Başkanıacibadem.com.tr
- 2003 - 2004MD Anderson Kanser Merkezi Meme Kanseri Klinik Araştırma (Clinical Observer)acibadem.com.tr
- 2002 - 2009Erciyes Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı Medikal Onkoloji Bilim Dalı, Öğretim Üyesiacibadem.com.tr
- 1999 - 2002Erciyes Üniversitesi Tıp Fakültesi Medikal Onkoloji Uzmanlığıacibadem.com.tr
- 1994 - 1999Ankara Numune Eğitim ve Araştırma Hastanesi İç Hastalıkları Uzmanlığıacibadem.com.tr
Education
- 2010Acıbadem Üniversitesi Tıp Fakültesi / Profesör, Digeracibadem.com.tr
- 2003Erciyes Üniversitesi Tıp Fakültesi / Doçent, Digeracibadem.com.tr
- 2002Erciyes Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
- 1999Ankara Numune Eğitim ve Araştırma Hastanesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
- 1994Hacettepe Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologyacibadem.com.trFrom source
- InstitutionAcıbadem Maslak Hastanesiacibadem.com.trFrom source
- Area of workBreast NeoplasmsExtracted from 8 publications · Model version —From source
- Publications98 publicationsOpenAlexFrom source
- Last synchronised4 November 2026 20:56https://www.acibadem.com.tr/doktor/ozlem-er/acibadem.com.tr
Scientific work
Publications on Breast Neoplasms
-
Comparison of First-Line Pembrolizumab Monotherapy Versus Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Multicenter Real-World Study from Turkey
Medicina, 2026
DOI 10.3390/medicina62112136 Open-access full textSource: OpenAlex
-
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study
Molecular and Clinical Oncology, 2025
DOI 10.3892/mco.2025.2846 PMID 40297501 Open-access full textSource: OpenAlex
-
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group
Clinical Lung Cancer, 2025
DOI 10.1016/j.cllc.2025.07.015 PMID 40813186 2 citations (Europe PMC) Source: OpenAlex
-
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
BMC Cancer, 2024
DOI 10.1186/s12885-023-11783-5 PMID 38166764 6 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study
Cancers, 2024
DOI 10.3390/cancers16183213 PMID 39335184 8 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours—results from a Turkish multi-centre study
Japanese Journal of Clinical Oncology, 2024
DOI 10.1093/jjco/hyae002 PMID 38271177 1 citation (Europe PMC) Open-access full textSource: OpenAlex
-
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
BMC Cancer, 2023
DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Major and minor salivary gland cancers: A multicenter retrospective study
Head & Neck, 2023
DOI 10.1002/hed.27376 PMID 37084179 8 citations (Europe PMC) Open-access full textSource: OpenAlex
-
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group ( TOG ) study
Cancer Medicine, 2023
DOI 10.1002/cam4.6869 PMID 38140782 1 citation (Europe PMC) Open-access full textSource: OpenAlex
-
Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study
Diseases of the Colon & Rectum, 2023
DOI 10.1097/dcr.0000000000002646 PMID 36856669 3 citations (Europe PMC) Source: OpenAlex